These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 5753556)

  • 1. Genetic control of drug levels in man: phenylbutazone.
    Vesell ES; Page JG
    Science; 1968 Mar; 159(3822):1479-80. PubMed ID: 5753556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic control of drug levels in man: antipyrine.
    Vesell ES; Page JG
    Science; 1968 Jul; 161(3836):72-3. PubMed ID: 5690279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic control of phenylbutazone metabolism in man.
    Whittaker JA; Evans DA
    Br Med J; 1970 Nov; 4(5731):323-8. PubMed ID: 5528753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic control of dicumarol levels in man.
    Vesell ES; Page JG
    J Clin Invest; 1968 Dec; 47(12):2657-63. PubMed ID: 4177776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic and environmental factors affecting drug response in man.
    Vesell ES
    Fed Proc; 1972; 31(4):1253-69. PubMed ID: 4114107
    [No Abstract]   [Full Text] [Related]  

  • 6. Studies on drug metabolism. IV. Effects of high dose administration of pentobarbital and phenylbutazone on the plasma biologic half lives in various species.
    Kitagawa H; Kamataki T; Yoshida S
    Chem Pharm Bull (Tokyo); 1968 Dec; 16(12):2320-3. PubMed ID: 4975994
    [No Abstract]   [Full Text] [Related]  

  • 7. Genetic control of interindividual variations in the inducibility of aryl hydrocarbon hydroxylase in cultured human lymphocytes.
    Atlas SA; Vesell ES; Nebert DW
    Cancer Res; 1976 Dec; 36(12):4619-30. PubMed ID: 63323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic control of drug levels and of the induction of drug-metabolizing enzymes in man: individual variability in the extent of allopurinol and nortriptyline inhibition of drug metabolism.
    Vesell ES; Passananti GT; Greene FE; Page JG
    Ann N Y Acad Sci; 1971 Jul; 179():752-73. PubMed ID: 4105797
    [No Abstract]   [Full Text] [Related]  

  • 9. Aspects of drug metabolism relating to pharmacologic activity.
    Gillette JR
    Am J Pharm Sci Support Public Health; 1969; 141(2):64-75. PubMed ID: 4979429
    [No Abstract]   [Full Text] [Related]  

  • 10. Steady-state plasma levels of nortriptyline in twins: influence of genetic factors and drug therapy.
    Alexanderson B; Evans DA; Sjöqvist F
    Br Med J; 1969 Dec; 4(5686):764-8. PubMed ID: 5391106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent progress in pharmacogenetics.
    Vesell ES
    Adv Pharmacol (1962); 1969; 7():1-52. PubMed ID: 4190237
    [No Abstract]   [Full Text] [Related]  

  • 12. Diphenylhydantoin half-life in man and its inhibition by phenylbutazone: the role of genetic factors.
    Andreasen PB; Froland A; Skovsted L; Andersen SA; Hauge M
    Acta Med Scand; 1973 Jun; 193(6):561-4. PubMed ID: 4738705
    [No Abstract]   [Full Text] [Related]  

  • 13. Salicylate metabolism in twins. Evidence suggesting a genetic influence and induction of salicylurate formation.
    Furst DE; Gupta N; Paulus HE
    J Clin Invest; 1977 Jul; 60(1):32-42. PubMed ID: 559691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic control of the phenobarbital-induced shortening of plasma antipyrine half-lives in man.
    Vesell ES; Page JG
    J Clin Invest; 1969 Dec; 48(12):2202-9. PubMed ID: 5389794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of low estrogen combination oral contraceptive on metabolism of aspirin and phenylbutazone.
    Gupta KC; Joshi JV; Hazari K; Pohujani SM; Satoskar RS
    Int J Clin Pharmacol Ther Toxicol; 1982 Nov; 20(11):511-3. PubMed ID: 7174153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenylbutazone: factors influencing plasma concentrations.
    Davies DS
    J Int Med Res; 1977; 5 Suppl 2():15-9. PubMed ID: 913869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biliary lipid composition in monozygotic and dizygotic pairs of twins.
    Antero Kesäniemi Y; Koskenvuo M; Vuoristo M; Miettinen TA
    Gut; 1989 Dec; 30(12):1750-6. PubMed ID: 2612989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacogenetics.
    Evans DA
    Trans Med Soc Lond; 1970; 86():72-81. PubMed ID: 5531297
    [No Abstract]   [Full Text] [Related]  

  • 19. [Studies on the effect of uremia on phenylbutazone and aminophenazone metabolism in man].
    Leber HW; Harders A; Schütterle G
    Klin Wochenschr; 1972 Dec; 50(23):1092-6. PubMed ID: 4643487
    [No Abstract]   [Full Text] [Related]  

  • 20. Acetanilide oxidation in phenylbutazone-associated hypoplastic anaemia.
    Cunningham JL; Leyland MJ; Delamore IW; Evans DA
    Br Med J; 1974 Aug; 3(5926):313-7. PubMed ID: 4411815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.